Ironwood Pharmaceuticals IRWD Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's accounts receivable?
- Ironwood Pharmaceuticals (IRWD) reported accounts receivable of $105.84M in Q1 2026.
- How has Ironwood Pharmaceuticals's accounts receivable changed year-over-year?
- Ironwood Pharmaceuticals's accounts receivable increased by 166.1% year-over-year, from $39.77M to $105.84M.
- What is the long-term trend for Ironwood Pharmaceuticals's accounts receivable?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's accounts receivable has grown at a -17.5% compound annual growth rate (CAGR), from $122.35M to $46.75M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.